Gelteq Ltd
GELS · XNASCIK 1920092fmd_1HP6S3DEJE1WXC79DBZNB5X91MManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2022 to Jun 30, 2025, 5 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | 0 | – | 0 |
| Cost of revenue | – | – | 0 |
| Gross profit | – | – | 0 |
| Research and development | 1 | 0 | 1 |
| Operating income | (3) | (3) | (5) |
| Interest expense | 0 | 1 | 2 |
| Income before taxes | (4) | (4) | (7) |
| Net income | (4) | (4) | (7) |